Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
NCT05965479
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Gastrooesophageal Cancer
Interventions
DRUG:
Trastuzumab deruxtecan
Sponsor
University of Southampton
Collaborators
[object Object]
[object Object]